Wanbury Ltd
Wanbury Ltd Share Price Today: Live Updates & Key Insights
Get insights on Wanbury Ltd’s fundamentals, financials, shareholding, peer comparison, corporate actions & performance. Track key metrics, price trends & market sentiment for informed decisions. Explore all data at Motilal Oswal.
Wanbury Ltd Share Price Chart
WANBURY at 10 Jul 2026 05:12 PM Pharmaceuticals
297.85 +13.95(+4.91%)
Lowest Today 277.00
Highest Today 303.10
Today's Open 287.00
Prev. Close 283.90
52 Week High 329.70
52 Week Low 161.50
Wanbury Ltd Fundamentals
Traded Volume: 2,60,021
Market Cap(Cr): 1,040.67
Avg Traded Price 291.82
1 Year return 10.79%
Upper Circuit 303.1
Lower Circuit 277
P/E TTM 16.00
P/B Ratio 0.00
Traded Value(Cr) 774.47
EPS TTM 18.928
Book value/Share NaN
Dividend Yield 1Y 0.00%
Wanbury Ltd Share Price Performance
Shows the percentage change in stock price over different time periods
This section highlights Wanbury Ltd stock price performance across key timeframes, including 1-week, 1-month, 3-month, Year-To-Date (YTD), and 1-year returns. It provides insights into the Wanbury Ltd share price history, short-term movements, long-term trends, and overall investor sentiment
1W +3.87%
1M +12.08%
3M +27.59%
1Y +10.79%
YTD +23.48%
Wanbury Ltd Traded Volume Movement
Shows the trading volume over different time periods
This section highlights Wanbury Ltd daily and average traded volumes, offering insights into investor activity and market liquidity. Higher volumes than average often indicate rising interest, news impact, or shifting market sentiment
Yesterday 1.85L
Day Before Yesterday 1.25L
1W Avg 1.18L
1M Avg 1.65L
3M Avg 1.08L
Wanbury Ltd Technical Details
Wanbury Ltd technical indicators, such as support and resistance levels and pivot points, are calculated based on historical price and volume trends. These metrics help traders anticipate possible price movements and make informed trading decisions.
Support 1 275
Support 2 266
Support 3 260
Pivot Point : 281
Resistance 1 290
Resistance 2 296
Resistance 3 305
Wanbury Ltd Corporate Actions
Wanbury Ltd corporate actions include dividends, bonus issues, stock splits, and key company updates that may affect share price and investor sentiment. This section provides timely details on past and upcoming actions, including ex-date, record date, and payout ratio - helping investors make informed decisions based on Wanbury Ltd’s capital allocation strategies.
All
Ex-Date 29-Jul-2010 Type D Description 1.00/share@10.00% Record Date - Ratio 10.00
Ex-Date 12-Mar-2009 Type D Description 0.50/share@5.00% Record Date - Ratio 5.00
Ex-Date 13-Sep-2007 Type D Description 2.00/share@20.00% Record Date - Ratio 20.00
Dividends
Announcement Date 29-Jul-2010 Ex Dividend Date 29-Jul-2010 Dividend(%) 10
Announcement Date 12-Mar-2009 Ex Dividend Date 12-Mar-2009 Dividend(%) 5
Announcement Date 13-Sep-2007 Ex Dividend Date 13-Sep-2007 Dividend(%) 20
Bonus
No Bonus has been declared by WANBURY
Splits
No Split has been declared by WANBURY
Others
Rights No Rights has been declared by WANBURY
Wanbury Ltd Peer Comparison
Shows key financial metrics for the company and its peers
This section compares Wanbury Ltd with leading peers in the pharmaceuticals & biotechnology sector based on key metrics such as market capitalization, 1-year return, P/E (TTM), and PB ratio. It helps investors evaluate Wanbury Ltd's relative performance and valuation against major competitors.
Stock Name Fermenta Biotech Ltd ₹411.80 (+2.53%) M. Cap (Cr) 12.12 1 Yr Return (%) +15.03% P/E (TTM) 16.62 PB Ratio 2.97
Stock Name Bajaj Healthcare Ltd ₹348.70 (-0.40%) M. Cap (Cr) 11.74 1 Yr Return (%) -27.98% P/E (TTM) 74.45 PB Ratio 2.20
Stock Name Themis Medicare Ltd ₹116.96 (+0.78%) M. Cap (Cr) 10.77 1 Yr Return (%) -6.39% P/E (TTM) 941.71 PB Ratio 2.70
Stock Name Wanbury Ltd ₹297.85 (+4.91%) M. Cap (Cr) 10.41 1 Yr Return (%) +10.79% P/E (TTM) 15.74 PB Ratio 7.20
Stock Name Bharat Parenterals Ltd ₹1402.00 (-0.61%) M. Cap (Cr) 9.66 1 Yr Return (%) -3.35% P/E (TTM) -118.10 PB Ratio 3.00
Stock Name Kopran Ltd ₹196.82 (+3.94%) M. Cap (Cr) 9.50 1 Yr Return (%) +10.73% P/E (TTM) 36.93 PB Ratio 1.79
Stock Name Remus Pharmaceuticals Ltd ₹739.95 (-1.04%) M. Cap (Cr) 8.72 1 Yr Return (%) -16.84% P/E (TTM) 23.57 PB Ratio 2.48
Wanbury Ltd Cash Flow
Cash flow data provides a view of how money is generated and spent by Wanbury Ltd, across its operating activities, investing activities, and financing activities.
PARTICULARS Operating Activities Mar 2026 31.53 Mar 2025 26.10 Mar 2024 4.02 Mar 2023 19.80 Mar 2022 40.52
PARTICULARS Investing Activities Mar 2026 -56.40 Mar 2025 -51.17 Mar 2024 -16.63 Mar 2023 -8.84 Mar 2022 0.59
PARTICULARS Financing Activities Mar 2026 22.42 Mar 2025 25.73 Mar 2024 14.55 Mar 2023 -31.99 Mar 2022 -28.58
PARTICULARS Net Cash Flow Mar 2026 -2.45 Mar 2025 0.66 Mar 2024 1.94 Mar 2023 -21.03 Mar 2022 12.52
Wanbury Ltd Shareholding Pattern
This shows the ownership breakdown of Wanbury Ltd, highlighting participation from Foreign Institutional Investors (FII), Mutual Funds, Public, Other Institutions, and Promoters.
Promoter 43.02%
Public 56.39%
Other Institutions 0.0%
FII 0.59%
Mutual Funds N/A%
About Wanbury Ltd
Wanbury Limited, formerly known Pearl Organics Limited was incorporated in August, 1988. The Company attained its present name in September 2004. The Company is engaged in the business of pharmaceutical and related activities, including research.The company has established its first plant in the year 1992 in Tarapur for manufacturing APIs. In 1995, the Company acquired plant of Brij Chemicals Pvt Ltd at Patalganga. In 1996, it entered into a strategic alliance with Wyckoff Chemicals to manufacture its API in US.In 2007-08, the merger of Doctors Organic Chemicals Limited (DOCL) with the Company became effective from 1st April, 2007. Pursuant to the aforesaid Order of the Hon'ble Bl FR 7,85,557 Equity Shares of face value of Rs. 10/- each of the Company were issued to the Equity Shareholders of DOCL on 17th March, 2008. Similarly, the Pharmaceutical Products of India Limited (PPIL) was merged with the Company effective from April 1, 2006. In terms of the said Scheme of Merger, the Company had issued 5,62,618 Equity Shares of face value of Rs. 10/- each to the Equity Shareholders of PPIL on 27 June, 2007, which got listed on Bombay Stock Exchange Limited and National Stock Exchange Limited respectively.The company entered into a strategic association with Bravo Healthcare Ltd and incorporated Ningxia Wanbury Fine Chemicals Co Ltd to source raw materials from China. It opened its office in Zurich,Switzerland for its CRAMS business and incorporated Wanbury Global FZE in Middle East for carrying out its trading activities in the year 2008.The novel product 'Cdense Gems' was launched in May, 2008. The Company completed the restructuring of the Formulation Division during the year 2013. It launched, Myotol-F, targeted at female infertility in 2013, it launched Folinine. The Company's newly launched products Myotol-F (to treat polycystic ovarian syndrome) and Cal-K2 (in prevention and management of Osteoporosis) were labelled as one of the best launches in 2014.
E D & Wholetime Director
K Chandran
Registered office BSEL Tech Park B-Wing 10th Flr, Sector 30 A Opp Vashi Rly Stat, Navi Mumbai, Maharashtra, 400703
FAX :91-22-67942222
Background
Incorporation Year 1988
Face Value ₹10.00
Market Lot 1
FAQs on Wanbury Ltd
How to buy Wanbury Ltd shares?
To buy Wanbury Ltd shares in Motilal Oswal, you just need to open a demat account and get your KYC documents verified.
What is the market cap of Wanbury Ltd?
The company has a market capitalization of ₹1,040.67.
What is the PE & PB ratio of Wanbury Ltd?
PE is 16 and PB is N/A.
What is the Wanbury Ltd dividend for 2025–26?
For the 2025–26 financial year, Wanbury Ltd declared a final dividend of 0.00% per share.